Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2016 · 10-Q
Revenue$117.00K$117.00Kno prior Q3 2015 on file Net Income-$3.25M-$3.25MN/M vs Q3 2015 EPS Diluted-$2.06-$2.06— vs Q3 2015 Operating Income-$1,682,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-1437.6%
Net margin-2781.2%
ended Sep 30, 2016 · filed Oct 17, 2016 · 17 d after period end